1 Center for Brain Health, Department of Psychiatry, and.
2 Division of Pulmonary, Critical Care and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
Am J Respir Crit Care Med. 2018 Apr 1;197(7):933-943. doi: 10.1164/rccm.201704-0704OC.
Recent evidence suggests that obstructive sleep apnea (OSA) may be a risk factor for developing mild cognitive impairment and Alzheimer's disease. However, how sleep apnea affects longitudinal risk for Alzheimer's disease is less well understood.
To test the hypothesis that there is an association between severity of OSA and longitudinal increase in amyloid burden in cognitively normal elderly.
Data were derived from a 2-year prospective longitudinal study that sampled community-dwelling healthy cognitively normal elderly. Subjects were healthy volunteers between the ages of 55 and 90, were nondepressed, and had a consensus clinical diagnosis of cognitively normal. Cerebrospinal fluid amyloid β was measured using ELISA. Subjects received Pittsburgh compound B positron emission tomography scans following standardized procedures. Monitoring of OSA was completed using a home sleep recording device.
We found that severity of OSA indices (AHIall [F = 4.26; P < 0.05] and AHI4% [F = 4.36; P < 0.05]) were associated with annual rate of change of cerebrospinal fluid amyloid β using linear regression after adjusting for age, sex, body mass index, and apolipoprotein E4 status. AHIall and AHI4% were not associated with increases in AD-mask (Alzheimer's disease vulnerable regions of interest Pittsburg compound B positron emission tomography mask) most likely because of the small sample size, although there was a trend for AHIall (F = 2.96, P = 0.09; and F = 2.32, not significant, respectively).
In a sample of cognitively normal elderly, OSA was associated with markers of increased amyloid burden over the 2-year follow-up. Sleep fragmentation and/or intermittent hypoxia from OSA are likely candidate mechanisms. If confirmed, clinical interventions for OSA may be useful in preventing amyloid build-up in cognitively normal elderly.
最近的证据表明,阻塞性睡眠呼吸暂停(OSA)可能是导致轻度认知障碍和阿尔茨海默病的危险因素。然而,睡眠呼吸暂停如何影响阿尔茨海默病的纵向风险尚不清楚。
检验假设,即 OSA 的严重程度与认知正常的老年人群中淀粉样蛋白负荷的纵向增加之间存在关联。
数据来自一项为期 2 年的前瞻性纵向研究,该研究对居住在社区的健康认知正常的老年人进行了抽样。研究对象为年龄在 55 至 90 岁之间、无抑郁且经共识临床诊断为认知正常的健康志愿者。使用 ELISA 法测量脑脊液淀粉样蛋白β。按照标准程序对受试者进行匹兹堡化合物 B 正电子发射断层扫描。使用家用睡眠记录设备监测 OSA。
我们发现,调整年龄、性别、体重指数和载脂蛋白 E4 状态后,使用线性回归,OSA 指数(AHIall[F=4.26;P<0.05]和 AHI4%[F=4.36;P<0.05])的严重程度与脑脊液淀粉样蛋白β的年变化率相关。AHIall 和 AHI4% 与 AD 掩蔽(阿尔茨海默病易感区域的匹兹堡化合物 B 正电子发射断层扫描掩蔽)的增加无关,这可能是由于样本量较小,尽管 AHIall 有增加的趋势(F=2.96,P=0.09;F=2.32,无显著意义)。
在认知正常的老年人样本中,OSA 与 2 年随访期间淀粉样蛋白负荷增加的标志物相关。OSA 引起的睡眠片段化和/或间歇性缺氧可能是潜在的机制。如果得到证实,针对 OSA 的临床干预措施可能有助于预防认知正常的老年人的淀粉样蛋白堆积。